Dulera 50mcg/5mcg Aerosol

Manufacturer ORGANON Active Ingredient Mometasone and Formoterol(moe MET a sone & for MOH te rol) Pronunciation moe MET a sone & for MOH te rol
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Antiasthmatic; Bronchodilator
🧬
Pharmacologic Class
Inhaled Corticosteroid (ICS) / Long-Acting Beta2-Adrenergic Agonist (LABA) Combination
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jun 2010
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Dulera is an inhaler that contains two medicines: a corticosteroid (mometasone) to reduce inflammation in your lungs and a long-acting bronchodilator (formoterol) to help keep your airways open. It is used twice a day, every day, to help control asthma symptoms and prevent flare-ups. It is NOT for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Proper Use of Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for inhalation only.

Preparing Your Inhaler

Before using your inhaler for the first time or if you haven't used it in more than 5 days, prime it by spraying 4 times into the air, away from your face and eyes. Shake the inhaler well before each use.

Using Your Inhaler

Continue to use this medication as directed by your doctor or healthcare provider, even if you're feeling well. Avoid getting the medication in your eyes. If it does get in your eyes, rinse them with plenty of water. If eye irritation persists, consult your doctor.

After each use, shake the inhaler well, rinse your mouth with water, and spit it out - do not swallow the rinse water. Replace the cap on the inhaler after each use.

Tracking Your Doses

If your inhaler has a dose counter, dispose of the inhaler when the counter reaches "0".

Important Safety Precautions

Do not use your inhaler near an open flame or while smoking, as it may burst. Use a new inhaler with each refill, and only use the device provided with this medication. Do not use any other devices or take the device apart. Clean the mouthpiece with a dry wipe at least every 7 days.

If you're using multiple inhaled medications, ask your doctor which one to use first.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from bathrooms. For the 60-puff inhaler, store it with the mouthpiece down or sideways. The storage position doesn't matter for the 120-puff inhaler.

Missing a Dose

If you miss a dose, skip it and return to your regular schedule. Do not take two doses at the same time or extra doses.
πŸ’‘

Lifestyle & Tips

  • Use Dulera regularly, twice a day, every day, even if you feel well.
  • Do NOT use Dulera for sudden breathing problems; use your rescue inhaler (e.g., albuterol) for acute symptoms.
  • Rinse your mouth with water and spit it out after each use of Dulera to help prevent oral thrush (a fungal infection in the mouth).
  • Do not exceed the prescribed dose.
  • Keep track of the number of inhalations used and discard the inhaler after the labeled number of doses or expiration date.
  • Avoid asthma triggers (e.g., allergens, irritants, smoke).

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Two inhalations of Dulera 100 mcg/5 mcg or Dulera 200 mcg/5 mcg twice daily (morning and evening). Note: Dulera 50mcg/5mcg is not an available strength.

Condition-Specific Dosing:

asthmaMaintenance: Two inhalations of Dulera 100 mcg/5 mcg or Dulera 200 mcg/5 mcg twice daily. Not for acute bronchospasm.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for children under 12 years of age.
Adolescent: Two inhalations of Dulera 100 mcg/5 mcg or Dulera 200 mcg/5 mcg twice daily (ages 12 years and older).
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment recommended.
Moderate: No dosage adjustment recommended.
Severe: No dosage adjustment recommended.
Dialysis: No specific recommendations; systemic exposure is low.

Hepatic Impairment:

Mild: No dosage adjustment recommended.
Moderate: No dosage adjustment recommended.
Severe: Use with caution; increased systemic exposure to mometasone is possible due to extensive hepatic metabolism.

Pharmacology

πŸ”¬

Mechanism of Action

Mometasone furoate is a corticosteroid that exhibits potent anti-inflammatory activity. It inhibits multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in allergic and non-allergic mediated inflammation. Formoterol fumarate is a long-acting selective beta2-adrenergic agonist (LABA) that stimulates adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of the release of mediators of immediate hypersensitivity from cells, especially from mast cells.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Mometasone: <1% (systemic after oral inhalation); Formoterol: ~10% (systemic after oral inhalation)
Tmax: Mometasone: 1-2 hours; Formoterol: 10-20 minutes
FoodEffect: Not applicable for inhaled aerosol.

Distribution:

Vd: Mometasone: ~152 L; Formoterol: ~4 L/kg
ProteinBinding: Mometasone: ~98-99%; Formoterol: ~61-64%
CnssPenetration: Limited

Elimination:

HalfLife: Mometasone: ~5.8 hours (IV); Formoterol: ~10 hours
Clearance: Not available
ExcretionRoute: Mometasone: Primarily feces, some urine; Formoterol: ~60% urine, ~30% feces
Unchanged: Mometasone: Very low; Formoterol: ~6-10% (urine)
⏱️

Pharmacodynamics

OnsetOfAction: Formoterol: 1-3 minutes
PeakEffect: Formoterol: 1-2 hours
DurationOfAction: Formoterol: Up to 12 hours
Confidence: Medium

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as formoterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and effectiveness of Dulera in patients with asthma have not been established in children less than 12 years of age. Dulera is not indicated for the relief of acute bronchospasm.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical help immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of infection, including:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of high blood sugar, such as:
+ Confusion
+ Drowsiness
+ Excessive thirst or hunger
+ Frequent urination
+ Flushing
+ Rapid breathing
+ Fruity-smelling breath
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ Abnormal heartbeat
Signs of a weak adrenal gland, such as:
+ Severe nausea or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Fatigue
+ Mood changes
+ Decreased appetite
+ Weight loss
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Fainting
+ Changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Feeling nervous or excitable
Shakiness
Seizures
Sleep disturbances
Severe nausea or vomiting
Redness or white patches in the mouth or throat
Changes in vision, eye pain, or severe eye irritation
Fatigue or weakness
Flushing

Breathing Problems: A Life-Threatening Condition

This medication can cause severe breathing problems, which may be life-threatening. If you experience trouble breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek medical help immediately.

Other Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you experience any of the following:

Headache
Nose or throat irritation
Common cold symptoms
* Flu-like symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough, chest tightness)
  • Increased need for your rescue inhaler
  • Signs of infection (e.g., fever, chills, increased mucus, change in mucus color)
  • Signs of oral thrush (white patches in your mouth or throat)
  • Signs of allergic reaction (e.g., rash, hives, swelling of face/lips/tongue, difficulty breathing)
  • Cardiovascular symptoms (e.g., fast or irregular heartbeat, chest pain, dizziness)
  • Muscle cramps or weakness
  • Vision changes (e.g., blurred vision, glaucoma, cataracts)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking another medication that is similar to this one. If you are unsure, consult your doctor or pharmacist for clarification.

This list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine whether it is safe to take this medication in conjunction with your other medications and health conditions.

Remember, do not start, stop, or adjust the dosage of any medication without first consulting your doctor to ensure your safety.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you have diabetes (high blood sugar), consult with your doctor, as this drug may increase your blood sugar levels.

You may not experience the full effects of this medication for a few weeks. If your breathing problems worsen, your rescue inhaler is less effective, or you need to use it more frequently, contact your doctor immediately.

Do not exceed the recommended dose or frequency of this medication, as overdoses of this type of drug have been fatal. Consult with your doctor if you have any concerns.

If you have been taking this medication for an extended period, discuss tapering off the medication with your doctor before stopping, as abrupt cessation may be harmful.

When transitioning from an oral steroid to another form of steroid, you may be at risk for severe and potentially life-threatening side effects, including weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar. If you experience any of these symptoms, contact your doctor immediately.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in such situations.

Long-term use of this medication may increase your risk of developing cataracts or glaucoma. Consult with your doctor and undergo regular eye exams as recommended.

Prolonged use of this medication may also lead to osteoporosis (weak bones). Discuss your risk factors and any concerns with your doctor.

You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoiding close contact with individuals who have infections, colds, or flu.

If you have not had chickenpox or measles before, avoid exposure to these illnesses, as they can be severe or even fatal in individuals taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult with your doctor.

In some cases, this medication may affect growth in children and adolescents. Regular growth checks may be necessary, so discuss this with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, consult with your doctor to weigh the benefits and risks of this medication for both you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Exaggerated beta-agonist effects: tachycardia, palpitations, tremor, headache, nausea, vomiting, hypokalemia, hyperglycemia, hypertension, or hypotension.
  • Exaggerated systemic corticosteroid effects: adrenal suppression, Cushingoid features (long-term).

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. Consider cardioselective beta-blockers for severe cardiovascular effects, but use with extreme caution due to risk of bronchospasm.

Drug Interactions

🚫

Contraindicated Interactions

  • Other long-acting beta2-adrenergic agonists (LABAs)
  • Use as monotherapy for asthma (LABA component)
πŸ”΄

Major Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin, itraconazole, cobicistat-containing products) - may increase systemic exposure to mometasone, leading to increased risk of systemic corticosteroid effects.
  • Beta-adrenergic blockers (especially non-selective) - may block the pulmonary effect of formoterol and produce severe bronchospasm, particularly in patients with asthma. Should not be used concurrently.
  • Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs) - may potentiate the effect of formoterol on the cardiovascular system, increasing the risk of arrhythmias.
  • QT-prolonging drugs (e.g., quinidine, disopyramide, procainamide, phenothiazines, antihistamines, macrolides) - increased risk of ventricular arrhythmias with formoterol.
🟑

Moderate Interactions

  • Non-potassium-sparing diuretics (e.g., loop or thiazide diuretics) - may potentiate the hypokalemic effect of beta-agonists.
  • Xanthine derivatives (e.g., theophylline) and other sympathomimetics - may potentiate adverse cardiovascular effects.
  • Other inhaled corticosteroids - additive systemic effects.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary function tests (e.g., FEV1)

Rationale: To establish baseline lung function and assess asthma severity.

Timing: Prior to initiation of therapy.

Asthma control assessment (e.g., ACT score)

Rationale: To establish baseline symptom control.

Timing: Prior to initiation of therapy.

πŸ“Š

Routine Monitoring

Asthma symptoms and peak expiratory flow (PEF)

Frequency: Regularly, as part of patient's asthma action plan.

Target: Improved symptom control, stable or improved PEF.

Action Threshold: Worsening symptoms, increased rescue inhaler use, or decreased PEF may indicate loss of control and require re-evaluation.

Adverse effects (e.g., oral candidiasis, dysphonia, tremor, palpitations, hypokalemia, hyperglycemia)

Frequency: At each follow-up visit (e.g., every 3-6 months or as clinically indicated).

Target: Absence or minimal adverse effects.

Action Threshold: Persistent or severe adverse effects warrant dose adjustment or discontinuation.

Growth in pediatric patients

Frequency: Periodically (e.g., annually).

Target: Normal growth velocity.

Action Threshold: Growth suppression may require re-evaluation of therapy.

Bone mineral density (BMD)

Frequency: Consider for patients at high risk for decreased BMD or on long-term high-dose ICS.

Target: Stable BMD.

Action Threshold: Significant decrease in BMD may require intervention.

πŸ‘οΈ

Symptom Monitoring

  • Worsening asthma symptoms (e.g., increased wheezing, shortness of breath, cough)
  • Increased need for rescue inhaler (short-acting beta-agonist)
  • Signs of oral candidiasis (white patches in mouth/throat)
  • Signs of systemic corticosteroid effects (e.g., easy bruising, moon face, weight gain, adrenal insufficiency symptoms like fatigue, weakness, nausea, vomiting)
  • Cardiovascular symptoms (e.g., palpitations, chest pain, rapid heart rate)
  • Muscle cramps or weakness (hypokalemia)

Special Patient Groups

🀰

Pregnancy

Category C. There are no adequate and well-controlled studies of Dulera in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Monitor neonates of mothers receiving corticosteroids during pregnancy for signs of hypoadrenalism.

Trimester-Specific Risks:

First Trimester: Limited data, potential for fetal harm cannot be ruled out.
Second Trimester: Limited data, potential for fetal harm cannot be ruled out.
Third Trimester: Potential for hypoadrenalism in neonates if mother received significant systemic corticosteroid exposure.
🀱

Lactation

Mometasone and formoterol are excreted in the milk of lactating animals. It is not known whether Dulera is excreted in human milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Dulera and any potential adverse effects on the breastfed infant from Dulera or from the underlying maternal condition. Caution should be exercised when Dulera is administered to a nursing woman.

Infant Risk: L3 - Moderate risk. Monitor for signs of systemic corticosteroid effects (e.g., growth suppression) or beta-agonist effects (e.g., irritability, tremor, tachycardia) in the infant.
πŸ‘Ά

Pediatric Use

Approved for patients 12 years of age and older. Safety and effectiveness have not been established in children younger than 12 years of age. Monitor growth in pediatric patients receiving corticosteroids, as growth suppression has been observed.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, caution should be exercised in elderly patients due to the greater frequency of decreased hepatic, renal, or cardiac function, and concomitant disease or other drug therapy.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Dulera is a maintenance inhaler and should be used consistently twice daily, not as a rescue inhaler for acute symptoms.
  • Patients should be instructed to rinse their mouth with water and spit after each use to minimize the risk of oral candidiasis (thrush).
  • Due to the LABA component, Dulera carries a Black Box Warning regarding increased risk of asthma-related death when used as monotherapy in asthma. It should only be used in asthma as combination therapy with an ICS.
  • Regular follow-up is crucial to assess asthma control, adherence, and monitor for adverse effects.
  • Patients should be advised to contact their healthcare provider if their asthma symptoms worsen or if they need to use their rescue inhaler more frequently.
πŸ”„

Alternative Therapies

  • Inhaled corticosteroids (e.g., fluticasone, budesonide, mometasone monotherapy)
  • Long-acting beta2-agonists (e.g., salmeterol, formoterol monotherapy - generally not recommended for asthma without ICS)
  • Leukotriene receptor antagonists (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations)
  • Biologic therapies (e.g., omalizumab, mepolizumab, benralizumab, dupilumab for severe asthma)
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $200-$400+ per inhaler (120 actuations)
Insurance Coverage: Tier 2 or 3 (Brand-name prescription)
πŸ“š

General Drug Facts

If your symptoms or health condition do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it is a good idea to consult with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, do not hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider for clarification and guidance. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the name of the medication taken, the amount consumed, and the time it occurred.